Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "irbesartan amlodipine irbesartan Hypertension" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about irbesartan amlodipine irbesartan Hypertension for you to read. Along with our medical data and news we also list irbesartan amlodipine irbesartan Hypertension Clinical Trials, which are updated daily. BioPortfolio also has a large database of irbesartan amlodipine irbesartan Hypertension Companies for you to search.
Silver Spring, Md (PRWEB) November 25, 2015 In honor of Pulmonary Hypertension Awareness Month, the Pulmonary Hypertension Association (PHA) announces the nationâs Periwinkle Pi...
Using approved drugs in unconventional ways could help improve compliance in patients with hypertension, according to a study in The Journal of Clinical Hypertension.
According to current statistics, hypertension affects more than 33% of US adults. Despite the availability of several antihypertensive medications, the morbidity and mortality caused by hypertension is on the rise, suggesting the need for investigati...
MARKHAM, ONTARIO -- (Marketwired) -- 11/09/15 -- Results from the National Heart, Lung and Blood Institute (NHLBI) Systolic Blood Pressure Intervention Trial (SPRINT) will be presented at the American Heart Association's annual scientific meeting in Orlando, Florida this afternoon. SPRINT studied the results of controlling systolic blood pressure to a target of less than 120 millimeters of mercu...
Hypertension affects more than four million Australians but the cause of the disease has never been understood. In research published today and presented at an international scientific meeting this week in Vienna, Monash researchers reveal the cause ...
Dr Henry Black interviews Dr John Bisognano and discusses his approach to managing hypertension and treating resistant hypertension. Medscape Cardiology
Focus on two broad, important concepts emerging in the pharmacology and therapeutics of hypertension and kidney disease. Current Opinion in Nephrology and Hypertension
Cardiovascular diseases are the leading cause of death worldwide. As a prime example, pulmonary hypertension is especially lethal, with one-half of patients dying within three years of being diagnosed. Yale researchers have uncovered a novel cell typ...
The Novartis Foundation and its partners have begun screening patients in a Community-based Hypertension Improvement Project (ComHIP) in Ghana in a two-year program designed to evaluate the impact of an innovative healthcare model on hypertension management and control. With the new healthcare model, Novartis and its partners aim to evaluate the impact of innovative healthcare and improve the cont...
TUESDAY, Nov. 3, 2015 -- The first guidelines for diagnosis and treatment of pulmonary hypertension in children have been released by the American Heart Association and the American Thoracic Society. Pulmonary hypertension is a sometimes fatal...
FRIDAY, Sept. 4, 2015 -- Exercise can be beneficial and safe for people with pulmonary hypertension, researchers report. Pulmonary hypertension is a type of high blood pressure that affects the lungs and heart, causing breathing problems, fatigue...
Severe uncontrolled hypertension is now listed as a contraindication in the summary of product characteristics for Betmiga (mirabegron; Astellas). Blood pressure should be measured before starting treatment and monitored regularly during treatment, especially in patients with hypertension.
If you have hypertension, it pays to include a pharmacist in a medical care team.
Which hidden risks are the most likely to be lurking for patients with hypertension? Kidney International
PUNE, India, October 9, 2015 /PRNewswire/ -- According to the Pulmonary Hypertension - Global Market Research 2015-2019 report, hypertension treatment is shifting toward the use of combination therapies that employ two or more drugs and it may result in better outcomes for the industry. Complete report on pulmonary hypertension market spread across 65 pages, analyzing 4 major companies and suppo...
Hypertension affects more than four million Australians but the cause of the disease has never been understood. In research published today and presented at an international scientific meeting this week in Vienna, Monash researchers reveal the cause of hypertension and how the disease could be reversed.
(Oxford University Press USA) With the number of individuals affected by cognitive decline expected to rise over the next few decades, investigating its potential causes is of major public health interest. Two new studies published today in the Ameri...